Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Kidney Cancer
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Renal Cell Carcinoma (358
)
Kidney Medullary Carcinoma (96
)
Renal Cell Carcinoma (358
)
Kidney Medullary Carcinoma (96
)
›
Associations
(387)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
nivolumab + cabozantinib tablet
Sensitive: A1 - Approval
nivolumab + cabozantinib tablet
Sensitive
:
A1
nivolumab + cabozantinib tablet
Sensitive: A1 - Approval
nivolumab + cabozantinib tablet
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
avelumab + axitinib
Sensitive: A1 - Approval
avelumab + axitinib
Sensitive
:
A1
avelumab + axitinib
Sensitive: A1 - Approval
avelumab + axitinib
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
bevacizumab-awwb
Sensitive: A1 - Approval
bevacizumab-awwb
Sensitive
:
A1
bevacizumab-awwb
Sensitive: A1 - Approval
bevacizumab-awwb
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
bevacizumab-bvzr
Sensitive: A1 - Approval
bevacizumab-bvzr
Sensitive
:
A1
bevacizumab-bvzr
Sensitive: A1 - Approval
bevacizumab-bvzr
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
sorafenib
Sensitive: A1 - Approval
sorafenib
Sensitive
:
A1
sorafenib
Sensitive: A1 - Approval
sorafenib
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
tivozanib
Sensitive: A1 - Approval
tivozanib
Sensitive
:
A1
tivozanib
Sensitive: A1 - Approval
tivozanib
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
temsirolimus
Sensitive: A1 - Approval
temsirolimus
Sensitive
:
A1
temsirolimus
Sensitive: A1 - Approval
temsirolimus
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
everolimus + lenvatinib
Sensitive: A1 - Approval
everolimus + lenvatinib
Sensitive
:
A1
everolimus + lenvatinib
Sensitive: A1 - Approval
everolimus + lenvatinib
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
everolimus
Sensitive: A1 - Approval
everolimus
Sensitive
:
A1
everolimus
Sensitive: A1 - Approval
everolimus
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
bevacizumab + pegylated interferon α -2a
Sensitive: A1 - Approval
bevacizumab + pegylated interferon α -2a
Sensitive
:
A1
bevacizumab + pegylated interferon α -2a
Sensitive: A1 - Approval
bevacizumab + pegylated interferon α -2a
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
cabozantinib tablet
Sensitive: A1 - Approval
cabozantinib tablet
Sensitive
:
A1
cabozantinib tablet
Sensitive: A1 - Approval
cabozantinib tablet
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
pembrolizumab + lenvatinib
Sensitive: A1 - Approval
pembrolizumab + lenvatinib
Sensitive
:
A1
pembrolizumab + lenvatinib
Sensitive: A1 - Approval
pembrolizumab + lenvatinib
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
pembrolizumab + axitinib
Sensitive: A1 - Approval
pembrolizumab + axitinib
Sensitive
:
A1
pembrolizumab + axitinib
Sensitive: A1 - Approval
pembrolizumab + axitinib
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
nivolumab
Sensitive: A1 - Approval
nivolumab
Sensitive
:
A1
nivolumab
Sensitive: A1 - Approval
nivolumab
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
Aybintio (bevacizumab biosimilar) + pegylated interferon α -2a
Sensitive: A1 - Approval
Aybintio (bevacizumab biosimilar) + pegylated interferon α -2a
Sensitive
:
A1
Aybintio (bevacizumab biosimilar) + pegylated interferon α -2a
Sensitive: A1 - Approval
Aybintio (bevacizumab biosimilar) + pegylated interferon α -2a
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
Aybintio (bevacizumab biosimilar)
Sensitive: A1 - Approval
Aybintio (bevacizumab biosimilar)
Sensitive
:
A1
Aybintio (bevacizumab biosimilar)
Sensitive: A1 - Approval
Aybintio (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
nivolumab + ipilimumab
Sensitive: A1 - Approval
nivolumab + ipilimumab
Sensitive
:
A1
nivolumab + ipilimumab
Sensitive: A1 - Approval
nivolumab + ipilimumab
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
axitinib
Sensitive: A1 - Approval
axitinib
Sensitive
:
A1
axitinib
Sensitive: A1 - Approval
axitinib
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
pazopanib
Sensitive: A1 - Approval
pazopanib
Sensitive
:
A1
pazopanib
Sensitive: A1 - Approval
pazopanib
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
aldesleukin
Sensitive: A1 - Approval
aldesleukin
Sensitive
:
A1
aldesleukin
Sensitive: A1 - Approval
aldesleukin
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
bevacizumab-maly
Sensitive: A1 - Approval
bevacizumab-maly
Sensitive
:
A1
bevacizumab-maly
Sensitive: A1 - Approval
bevacizumab-maly
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
pembrolizumab
Sensitive: A1 - Approval
pembrolizumab
Sensitive
:
A1
pembrolizumab
Sensitive: A1 - Approval
pembrolizumab
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
Krabeva (bevacizumab biosimilar)
Sensitive: A1 - Approval
Krabeva (bevacizumab biosimilar)
Sensitive
:
A1
Krabeva (bevacizumab biosimilar)
Sensitive: A1 - Approval
Krabeva (bevacizumab biosimilar)
Sensitive
:
A1
VHL mutation
Renal Cell Carcinoma
VHL mutation
Renal Cell Carcinoma
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
bevacizumab-adcd
Sensitive: A1 - Approval
bevacizumab-adcd
Sensitive
:
A1
bevacizumab-adcd
Sensitive: A1 - Approval
bevacizumab-adcd
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
bevacizumab-tnjn
Sensitive: A1 - Approval
bevacizumab-tnjn
Sensitive
:
A1
bevacizumab-tnjn
Sensitive: A1 - Approval
bevacizumab-tnjn
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
bevacizumab
Sensitive: A2 - Guideline
bevacizumab
Sensitive
:
A2
bevacizumab
Sensitive: A2 - Guideline
bevacizumab
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
No biomarker
Clear Cell Renal Cell Carcinoma
bevacizumab + pegylated interferon α -2a
Sensitive: A2 - Guideline
bevacizumab + pegylated interferon α -2a
Sensitive
:
A2
bevacizumab + pegylated interferon α -2a
Sensitive: A2 - Guideline
bevacizumab + pegylated interferon α -2a
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
No biomarker
Clear Cell Renal Cell Carcinoma
avelumab + axitinib
Sensitive: A2 - Guideline
avelumab + axitinib
Sensitive
:
A2
avelumab + axitinib
Sensitive: A2 - Guideline
avelumab + axitinib
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
No biomarker
Clear Cell Renal Cell Carcinoma
pembrolizumab + axitinib
Sensitive: A2 - Guideline
pembrolizumab + axitinib
Sensitive
:
A2
pembrolizumab + axitinib
Sensitive: A2 - Guideline
pembrolizumab + axitinib
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login